Post-approval studies (Phase 4)WithdrawnNCT01097941What this trial is testingEffect of Age and Prior Immunity on Response to H1N1 Vaccines in ChildrenWho this might be right for2009 H1N1 Influenza University of Rochester
Testing effectiveness (Phase 2)Study completedNCT05074303What this trial is testingBeta-glucan and Immune Response to Influenza VaccineWho this might be right forHealthy Aging University of Florida 78
Post-approval studies (Phase 4)Study completedNCT03022422What this trial is testingT-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011Who this might be right forInfluenza Stanford University 63
Post-approval studies (Phase 4)Looking for participantsNCT05616546What this trial is testingBone Marrow and Peripheral Blood Immune Responses StudyWho this might be right forInfluenza Emory University 90
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Not applicableUnknownNCT00845403What this trial is testingAntigen-specific Immune Response to Hepatitis B Virus in UteroWho this might be right forHepatitis B National University Hospital, Singapore 60
Post-approval studies (Phase 4)Study completedNCT02133781What this trial is testingB-cell Immunity to Influenza (SLVP017)- Year 1, 2009Who this might be right forInfluenza Stanford University 51
Testing effectiveness (Phase 2)Study completedNCT01161160What this trial is testingSafety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years OldWho this might be right forInfluenza GlaxoSmithKline 209
Early research (Phase 1)Study completedNCT00510874What this trial is testingStudy to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in AdultsWho this might be right forInfluenza GlaxoSmithKline 780
Not applicableStudy completedNCT01522248What this trial is testingEarly Immune Responses to Inactivated Influenza Vaccine: a Pilot StudyWho this might be right forInfluenza Virus Vaccine Johns Hopkins Bloomberg School of Public Health 20
Not applicableStudy completedNCT04222595What this trial is testingFluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIVWho this might be right forImmunization University of Oxford 33
Testing effectiveness (Phase 2)Study completedNCT00461981What this trial is testingEvaluate Immune Responses of FluMist®Who this might be right forInfluenza Vaccine MedImmune LLC 101
Large-scale testing (Phase 3)WithdrawnNCT04848467What this trial is testingCOVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and OlderWho this might be right forSARS-CoV-2 InfectionCoronavirus Disease 2019 (COVID-19) Bayer
Large-scale testing (Phase 3)Study completedNCT04498832What this trial is testingStudy to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and OlderWho this might be right forInfluenza ImmunizationHealthy Volunteers Sanofi Pasteur, a Sanofi Company 2,100
Post-approval studies (Phase 4)Study completedNCT01946594What this trial is testingClinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIVWho this might be right forFever Duke University 41
Testing effectiveness (Phase 2)Study completedNCT07121192What this trial is testingAssess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and OlderWho this might be right forInfluenza, Human GlaxoSmithKline 776
Testing effectiveness (Phase 2)Study completedNCT02529904What this trial is testingADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and AdultsWho this might be right forInfluenza University of Oxford 120
Not applicableStudy completedNCT02415842What this trial is testingA Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza VaccinesWho this might be right forImmunologic Tests GlaxoSmithKline 414
Not applicableStudy completedNCT04188483What this trial is testingEffect of Selenium Supplementation on Influenza VaccinationWho this might be right forSelenium SupplementationInfluenza Vaccination Huazhong University of Science and Technology 60
Not applicableStudy completedNCT02900209What this trial is testingInfluenza Vaccination and COPD PhenotypesWho this might be right forPulmonary Disease, Chronic Obstructive University of Lincoln 54